Rate of Discontinuation from Home Infusion Therapy Due to Adverse Drug Reactions and Unplanned Hospitalizations – A Pilot Study
NHIF Research Rate of Discontinuation from Home Infusion Therapy Due to Adverse Drug Reactions and Unplanned Hospitalizations – A Pilot Study September/October 2021 By Danell J. Haines, PhD and Michelle Simpson, PharmD, BCSCP Abstract Background: Existing for more than 4 decades, the home and specialty infusion industry is well established. In 2019 alone more than 3.2 million patients were served.1
October 1, 2021
